share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144：拟议出售证券
SEC announcement ·  03/12 16:37
Moomoo AI 已提取核心信息
Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 25,000 Class A shares of the company on 03/12/2024, with an aggregate market value of $261,375.83. The shares were originally acquired on 04/20/2021 as pre-IPO shares from the issuer for the same amount and paid in cash. This upcoming sale follows a series of transactions over the past three months where a total of 150,000 shares were sold for gross proceeds of approximately $1.4 million.
Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 25,000 Class A shares of the company on 03/12/2024, with an aggregate market value of $261,375.83. The shares were originally acquired on 04/20/2021 as pre-IPO shares from the issuer for the same amount and paid in cash. This upcoming sale follows a series of transactions over the past three months where a total of 150,000 shares were sold for gross proceeds of approximately $1.4 million.
Recursion Pharmicals, Inc.高管塞科拉·迈克尔定于2024年12月3日出售该公司的25,000股A类股票，总市值为261,375.83美元。这些股票最初是在2021年4月20日作为首次公开募股前的股票以相同金额从发行人手中收购的，并以现金支付。此次即将进行的出售是在过去三个月进行的一系列交易之后进行的，共出售了15万股股票，总收益约为140万美元。
Recursion Pharmicals, Inc.高管塞科拉·迈克尔定于2024年12月3日出售该公司的25,000股A类股票，总市值为261,375.83美元。这些股票最初是在2021年4月20日作为首次公开募股前的股票以相同金额从发行人手中收购的，并以现金支付。此次即将进行的出售是在过去三个月进行的一系列交易之后进行的，共出售了15万股股票，总收益约为140万美元。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息